15 Hrs
Source:
Lebanese Forces
Source: Lebanese Forces
15 HrsLebanese Forces
Source: Lebanese Forces
15 HrsReady to play
Ready to play
A recent study has shown that the drug "Ousapadacinib" can help restore skin color in some vitiligo patients, with up to 75% repigmentation of the affected area after 48 weeks of daily treatment. The trials were conducted on 614 adults and adolescents across 138 institutions in 18 countries. The results indicated that approximately 25% of participants were able to recover three-quarters of their natural skin tone on the face, while 20% regained half of the lost pigmentation in other parts of the body. The medication works by calming the immune response responsible for vitiligo and is particularly beneficial for those with widespread vitiligo or areas that are difficult to treat with creams or light therapy. However, there are warnings about potential side effects such as inflammation, hives, and infections, as well as long-term risks including infections and cancer. The long-term efficacy of the treatment remains unconfirmed, and it is currently being monitored until a 112-week study is completed to further assess safety and sustained outcomes.
Notice: This Is an AI-Generated Summary
Comments (0)